Drug Shortage Report for VIOKACE
Report ID | 62330 |
Drug Identification Number | 02241933 |
Brand name | VIOKACE |
Common or Proper name | Viokace |
Company Name | NESTLE ENTERPRISES S.A. |
Market Status | MARKETED |
Active Ingredient(s) | AMYLASE PROTEASE LIPASE |
Strength(s) | 113400UNIT 112500UNIT 20880UNIT |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottle |
ATC code | A09AA |
ATC description | DIGESTIVES, INCL ENZYMES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-08-27 |
Estimated end date | 2018-10-12 |
Actual end date | 2016-10-05 |
Shortage status | Avoided shortage |
Updated date | 2018-10-09 |
Company comments | Production delay |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 12, RUE ENTRE-DEUX-VILLES VEVEY, -- SWITZERLAND 1800 |
Company contact information | kfeltmate@apcipharma.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-10-09 | French | Compare |
v3 | 2018-10-09 | English | Compare |
v2 | 2018-09-25 | French | Compare |
v1 | 2018-09-25 | English | Compare |
Showing 1 to 4 of 4